Loading...
•
Jun 30, 2022
Globus Medical Q2 2022 Earnings Report
Globus Medical's Q2 2022 results showed revenue growth and strong performance in enabling technologies.
Key Takeaways
Globus Medical reported a 5.0% increase in worldwide net sales to $263.6 million in Q2 2022. GAAP net income increased by 31.4% to $54.6 million, with diluted EPS at $0.53 and non-GAAP diluted EPS at $0.56. The Enabling Technologies business grew by 41.7% to $29.4 million.
Worldwide net sales increased by 5.0% to $263.6 million.
GAAP net income rose by 31.4% to $54.6 million.
Diluted EPS was $0.53, while non-GAAP diluted EPS was $0.56.
Enabling Technologies revenue grew by 41.7% to $29.4 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company today reaffirmed its full year 2022 guidance of $1.025 billion in net sales and non-GAAP diluted earnings per share of $2.10.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...